Homebiogas (Israel) Performance
| HMGS Stock | ILA 136.70 1.70 1.23% |
Homebiogas holds a performance score of 7 on a scale of zero to a hundred. The company retains a Market Volatility (i.e., Beta) of -0.81, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Homebiogas are expected to decrease at a much lower rate. During the bear market, Homebiogas is likely to outperform the market. Use Homebiogas standard deviation, total risk alpha, treynor ratio, as well as the relationship between the jensen alpha and sortino ratio , to analyze future returns on Homebiogas.
Risk-Adjusted Performance
OK
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Homebiogas are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Homebiogas sustained solid returns over the last few months and may actually be approaching a breakup point. ...more
Homebiogas |
Homebiogas Relative Risk vs. Return Landscape
If you would invest 10,560 in Homebiogas on December 18, 2024 and sell it today you would earn a total of 3,280 from holding Homebiogas or generate 31.06% return on investment over 90 days. Homebiogas is generating 1.0686% of daily returns and assumes 11.1611% volatility on return distribution over the 90 days horizon. Simply put, 99% of stocks are less volatile than Homebiogas, and 79% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Homebiogas Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Homebiogas' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Homebiogas, and traders can use it to determine the average amount a Homebiogas' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0957
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | HMGS | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 11.16 actual daily | 96 96% of assets are less volatile |
Expected Return
| 1.07 actual daily | 21 79% of assets have higher returns |
Risk-Adjusted Return
| 0.1 actual daily | 7 93% of assets perform better |
Based on monthly moving average Homebiogas is performing at about 7% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Homebiogas by adding it to a well-diversified portfolio.
Homebiogas Fundamentals Growth
Homebiogas Stock prices reflect investors' perceptions of the future prospects and financial health of Homebiogas, and Homebiogas fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Homebiogas Stock performance.
| Return On Equity | -0.53 | |||
| Return On Asset | -0.26 | |||
| Operating Margin | (4.17) % | |||
| Current Valuation | 83.15 M | |||
| Shares Outstanding | 19.64 M | |||
| Price To Book | 1.92 X | |||
| Price To Sales | 41.73 X | |||
| Revenue | 3.15 M | |||
| EBITDA | (12.8 M) | |||
| Cash And Equivalents | 16.43 M | |||
| Cash Per Share | 0.83 X | |||
| Total Debt | 1.8 M | |||
| Debt To Equity | 0.09 % | |||
| Book Value Per Share | 1.03 X | |||
| Cash Flow From Operations | (11.16 M) | |||
| Earnings Per Share | (0.44) X | |||
About Homebiogas Performance
By analyzing Homebiogas' fundamental ratios, stakeholders can gain valuable insights into Homebiogas' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Homebiogas has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Homebiogas has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
HomeBiogas LTD develops, produces, and markets biogas systems for treatment of organic waste into clean energy for households, farmers, businesses, and communities worldwide. HomeBiogas LTD was incorporated in 2012 and is headquartered in Beit Yanai, Israel. HOMEBIOGAS operates under UtilitiesRenewable classification in Israel and is traded on Tel Aviv Stock Exchange. It employs 93 people.Things to note about Homebiogas performance evaluation
Checking the ongoing alerts about Homebiogas for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Homebiogas help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Homebiogas is way too risky over 90 days horizon | |
| Homebiogas appears to be risky and price may revert if volatility continues | |
| The company reported the revenue of 3.15 M. Net Loss for the year was (14.03 M) with loss before overhead, payroll, taxes, and interest of (5 K). | |
| Homebiogas has accumulated about 16.43 M in cash with (11.16 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.83. | |
| Roughly 21.0% of the company shares are held by company insiders |
- Analyzing Homebiogas' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Homebiogas' stock is overvalued or undervalued compared to its peers.
- Examining Homebiogas' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Homebiogas' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Homebiogas' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Homebiogas' stock. These opinions can provide insight into Homebiogas' potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Homebiogas Stock analysis
When running Homebiogas' price analysis, check to measure Homebiogas' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Homebiogas is operating at the current time. Most of Homebiogas' value examination focuses on studying past and present price action to predict the probability of Homebiogas' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Homebiogas' price. Additionally, you may evaluate how the addition of Homebiogas to your portfolios can decrease your overall portfolio volatility.
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |